Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Contributed equally
BMC Cancer201717:810

https://doi.org/10.1186/s12885-017-3834-z

Received: 21 April 2017

Accepted: 23 November 2017

Published: 2 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Apr 2017 Submitted Original manuscript
12 Aug 2017 Reviewed Reviewer Report - Zhe Yang
17 Aug 2017 Reviewed Reviewer Report - Mahesh B. Chandrasekharan
24 Aug 2017 Author responded Author comments - Monika Bauden
Resubmission - Version 2
24 Aug 2017 Submitted Manuscript version 2
19 Nov 2017 Author responded Author comments - Monika Bauden
Resubmission - Version 3
19 Nov 2017 Submitted Manuscript version 3
Publishing
23 Nov 2017 Editorially accepted
2 Dec 2017 Article published 10.1186/s12885-017-3834-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital
(2)
Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University, Biomedical Center
(3)
Department of Pathology, Skåne University Hospital

Advertisement